Advances in CD247
Authors:
- 17 April 2022
- journal article
- review article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 96 (1) , e13170
Abstract
CD247, which is also known as CD3ζ, CD3H, CD3Q, CD3Z, IMD25, T3Z and TCRZ, encodes CD3ζ protein, which is expressed primarily in natural killer (NK) and T cells. Since the discovery of the ζ peptide in 1986, it has been continuously investigated. In this paper, we review the composition, molecular mechanisms and regulatory factors of CD247 expression in T cells; and review the autoimmune diseases, tumours and inflammatory diseases associated with CD247, providing a detailed and comprehensive reference for further research on the mechanism of CD247 and related diseases.Keywords
This publication has 110 references indexed in Scilit:
- Investigation of rheumatoid arthritis susceptibility loci in juvenile idiopathic arthritis confirms high degree of overlapAnnals of the Rheumatic Diseases, 2012
- Altered expression of the TCR signaling related genes CD3 and FcεRIγ in patients with aplastic anemiaJournal of Hematology & Oncology, 2012
- The CD3-Zeta Chimeric Antigen Receptor Overcomes TCR Hypo-Responsiveness of Human Terminal Late-Stage T CellsPLOS ONE, 2012
- The Shc Family Protein Adaptor, Rai, Negatively Regulates T Cell Antigen Receptor Signaling by Inhibiting ZAP-70 Recruitment and ActivationPLOS ONE, 2011
- K33-Linked Polyubiquitination of T Cell Receptor-ζ Regulates Proteolysis-Independent T Cell SignalingImmunity, 2010
- Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locusNature Genetics, 2010
- Alternative Splicing Factor/Splicing Factor 2 Regulates the Expression of the ζ Subunit of the Human T Cell Receptor-associated CD3 ComplexJournal of Biological Chemistry, 2010
- The Immune Protein CD3ζ Is Required for Normal Development of Neural Circuits in the RetinaNeuron, 2010
- The RNA-stabilizing Protein HuR Regulates the Expression of ζ Chain of the Human T Cell Receptor-associated CD3 ComplexJournal of Biological Chemistry, 2008
- Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsisBlood, 2007